Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Contraceptive Technology Update

RSS  

Articles

  • ‘Quick Start’ approach eyed for DMPA and patch

    Current package labeling for the contraceptive injection depot medroxyprogesterone acetate (DMPA) (Depo-Provera, Pfizer, New York City) calls for the method to be initiated within the first five days of a womans menstrual period.
  • Shortening the pill-free interval: New contraceptives take next step

    Do you remember Enovid, the first oral contraceptive (OC)? Introduced in 1960 by GD Searle in Skokie, IL, the pill was formulated for 21 days of active hormones, followed by seven hormone-free days. During the pill-free interval, the superficial portion of the endometrium was sloughed, producing a withdrawal bleeding episode that simulated menstruation.
  • Use the phone and web to expand EC access

    While women wait for a decision from the Food and Drug Administration (FDA) on the status of moving emergency contraception over the counter (OTC), some family planning providers are looking at using the telephone and Internet to help expand access to the method.
  • Does contraceptive use impact cancer risk?

    Contraceptive use has been reported as a risk factor for cervical cancer; however, since the discovery of the strong link between human papillomavirus (HPV) infection and cervical cancer, evidence has been unclear on its association.
  • Take aim at eliminating spread of hepatitis B virus in U.S. population

    When discussing prevention strategies against sexually transmitted diseases (STDs) with your patients, do you discuss immunization against hepatitis B? The message may not be getting through; 42% of 1,150 adults ages 18-35 participating in a 2004 national survey did not know they could protect themselves from hepatitis B virus (HBV) infection through vaccination.
  • Scientists eye delivery options in microbicides

    The last patient on your list is a young woman with a positive test for a sexually transmitted disease (STD). When discussing strategies for protection from future infections, she tells you she is not comfortable with using a female condom and has problems negotiating male condom use with her boyfriend. Outside of abstinence, what are her options?
  • Research signals safety of Pill use in lupus

    Women with inactive or stable systemic lupus erythematosus a disease in which the bodys immune system mistakenly attacks and damages healthy tissues of the skin, joints and internal organs need effective contraception When women with inactive or stable systemic lupus erythematosus need effective contraception, clinicians rarely prescribe oral contraceptives (OCs) due to fears that the Pill might increase disease activity.
  • Use the Internet to set up hepatitis B programs

    If it does not, what will it take to integrate an immunization program into existing services? Take a tip from the Internet. Consult the online guide, Hepatitis B Immunization in a STD Clinic: Lessons Learned in San Diego County.
  • CTU remembers Felicia Stewart, MD

    Felicia Hance Stewart, MD, co-author of Contraceptive Technology and member of the Contraceptive Technology Update Editorial Board, died April 12 of lung cancer at her home in San Carlos, CA.
  • Where does your state stand on EC in the ED?

    A new patient tells you that she is a recent victim of sexual assault. What care was she provided when she underwent treatment at your local hospital's emergency department (ED)?